Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2026

Mar 17, 2026

29871_dirs_2026-03-17_451f90dd-6354-43d9-ac59-b162a98eb54f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2026-03-15

Reporting Person: Vroman Ken (Chief Transformation Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-03-15 Common Stock Class A A 7076 $311.40 Acquired 21986 Direct
2026-03-15 Common Stock Class A F 3135 $311.40 Disposed 18851 Direct

Footnotes

F1: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.

F2: Mr. Vroman surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.